Sort
261,768 grants matching “gene therapy”
Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear
$1,128,068Michael Hoa · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
BROAD-SPECTRUM RNAi THERAPEUTICS FOR FLAVIVIRAL ENCEPHALITIS
$1,128,000Manjunath Narasimha Swamy · Immune Disease Institute, Inc. · U01 · FY2007 · AI
Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimer's Disease
$1,127,955John Didsbury · T3d Therapeutics, Inc. · R44 · FY2015 · AG
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,127,706Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Lysosomal Disease Network
$1,127,583Chester B Whitley · University Of Minnesota · U54 · FY2022 · NS
Predicting Weight Regain Following Weight Loss Using Physiological Measures of Appetite and Energy Expenditure
$1,127,574Michael R Lowe · Drexel University · UH3 · FY2025 · DK
Comparative Mammalian Genomics
$1,127,526Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2015 · HG
Mid-Atlantic Nutrition Obesity Research Center
$1,127,514Alan R. Shuldiner · University Of Maryland Baltimore · P30 · FY2014 · DK
Molecular Biology Of Outer Retina-specific Proteins
$1,127,444Thomas Redmond · National Eye Institute · ZIA · FY2012 · EY
La Spada Outstanding Investigator Award
$1,127,433Albert R La Spada · University Of California-Irvine · R35 · FY2024 · NS
Molecular Biology Of Outer Retina-specific Proteins
$1,127,410Thomas Redmond · National Eye Institute · ZIA · FY2014 · EY
RNA-programmable cell-type targeting, editing, and therapy
$1,127,000Z Josh Huang · Duke University · DP1 · FY2025 · MH
RNA-programmable cell-type targeting, editing, and therapy
$1,127,000Z Josh Huang · Duke University · DP1 · FY2024 · MH
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2023 · AI
RNA-programmable cell-type targeting, editing, and therapy
$1,127,000Z Josh Huang · Duke University · DP1 · FY2021 · MH
RNA-programmable cell-type targeting, editing, and therapy
$1,127,000Z Josh Huang · Duke University · DP1 · FY2022 · MH
RNA-programmable cell-type targeting, editing, and therapy
$1,127,000Z Josh Huang · Duke University · DP1 · FY2023 · MH
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2025 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2022 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2021 · AI
Defining the viral PTMome: Towards the development of novel antiviral approaches
$1,127,000Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · DP1 · FY2024 · AI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?
$1,126,986Evan D Morris · Yale University · R01 · FY2022 · DA
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,126,964Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2023 · DK
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$1,126,913Alan Sher · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
MOLECULAR CLASSIFICATION OF COLON TUMORS
$1,126,811Montefiore Medical Center (Bronx, Ny) · U01 · FY2004 · CA